Loading…
Secretory Nogo-B regulates Th2 differentiation in the lung cancer microenvironment
•Nogo-B is highly secreted by lung cancer cells.•The concentration of Nogo-B in the serum of lung cancer patients was significantly elevated and showed a significant positive correlation with tumor size.•ER stress and phosphorylation at S107 promote the secretion of Nogo-B in lung cancer cells.•Secr...
Saved in:
Published in: | International immunopharmacology 2024-10, Vol.140, p.112763, Article 112763 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | •Nogo-B is highly secreted by lung cancer cells.•The concentration of Nogo-B in the serum of lung cancer patients was significantly elevated and showed a significant positive correlation with tumor size.•ER stress and phosphorylation at S107 promote the secretion of Nogo-B in lung cancer cells.•Secretory Nogo-B may reshape the tumor immune microenvironment and promote tumor progression by inhibiting the function of tumor-infiltrating immune cells, especially Th2 cells.
Nogo-B, a ubiquitously expressed member of the reticulon family, plays an important role in maintaining endoplasmic reticulum (ER) structure, regulating protein folding, and calcium homeostasis. In this study, we demonstrate that Nogo-B expression and secretion are upregulated in lung cancer and correlate to overall survival. Nogo-B is secreted by various cells, particularly lung cancer cells. ER stress and phosphorylation at serine 107 can induce Nogo-B secretion. Secretory Nogo-B suppresses the differentiation of Th2 cells and the release of type 2 cytokines, thus influencing the anti-tumor effects of Th2-related immune cells, including IgE+B cell class switching and eosinophil activation. |
---|---|
ISSN: | 1567-5769 1878-1705 1878-1705 |
DOI: | 10.1016/j.intimp.2024.112763 |